Clinical Trial Update: Intravenous Triple Therapy in the Treatment of Helicobacter Pylori Infection and Related Complications Caused by Active Peptic Ulcer Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating intravenous triple therapy for Helicobacter pylori infection and related complications from active peptic ulcer disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection
• Peptic Ulcer Disease

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Helicobacter Pylori Infection, Intravenous Drug Usage | Phase 4 | Status: UNKNOWN